Top

Published in:

01-02-2019 | Original Article

Adipocyte proteome and secretome influence inflammatory and hormone pathways in glioma

Authors: J. Almeida, J. Costa, P. Coelho, V. Cea, M. Galesio, J. P. Noronha, M. S. Diniz, C. Prudêncio, R. Soares, C. Sala, Rúben Fernandes

Published in: Metabolic Brain Disease | Issue 1/2019

Abstract

Gliomas represent the most common primary malignant brain tumors in adults, with an extremely poor prognosis. Among several risk factors, lifestyle was also recently identified as a major risk factor for the development of primary glioma. In the present study, we explore the relationship between obesity and glioma in a cellular model. Thus, we have study the influence of adipocytes secretome on glioma cell line GL261. Using the 3T3-L1 adipocyte cell line, and its conditioned medium (adipokines-enriched medium), we showed that adipocyte-released factors relate with glioma angiogenic, growth, hormones and metabolic behavior by MALDI-TOF-MS and proteomic array analysis. In a first view, STI1, hnRNPs and PGK1 are under expressed on CGl. Similarly, both carbonic anhydrase and aldose reductase are even suppressed in glioma cells that grown under adipokines-enriched environment. Contrariwise, RFC1, KIF5C, ANXA2, N-RAP and RACK1 are overexpressed in GL261 cell the in the presence of the adipokines-enriched medium. We further identified the factors that are released by adipocyte cells, and revealed that several pro-inflammatory and angiogenic factors, such as IL-6, IL-11, LIF, PAI-1, TNF-α, endocan, HGF, VEGF IGF-I, were secreted to the medium into a high extent, whereas TIMP-1 and SerpinE1 were under expressed on CGl. This study discloses an interesting in vitro model for the study of glioma biology under a “obesity” environment, that can be explored for the understanding of cancer cells biology, for the search of biomarkers, prognostic markers and therapeutic approaches.

Available only for authorised users

Aoki T, Kato S, Fox JC, Okamoto K, Sakata K, Morimatsu M, Shigemori M (2002) Inhibition of autocrine fibroblast growth factor signaling by the adenovirus-mediated expression of an antisense transgene or a dominant negative receptor in human glioma cells in vitro. Int J Oncol 21:629–636PubMed

Bainbridge MN, Armstrong GN, Gramatges MM et al (2014) Germline mutations in Shelterin complex genes are associated with familial glioma. JNCI J Natl Cancer Inst 107:dju384–dju384. https://doi.org/10.1093/jnci/dju384 CrossRefPubMed

Benson VS, Pirie K, Green J et al (2008) Lifestyle factors and primary glioma and meningioma tumours in the million women study cohort. Br J Cancer 99:185–190. https://doi.org/10.1038/sj.bjc.6604445 CrossRefPubMedPubMedCentral

Calle EE, Thun MJ (2004) Obesity and cancer. Oncogene 23:6365–6378. https://doi.org/10.1038/sj.onc.1207751 CrossRefPubMed

Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr (1999) Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097–1105. https://doi.org/10.1056/NEJM199910073411501 CrossRefPubMed

Candolfi M, Curtin JF, Nichols WS, Muhammad AKMG, King GD, Pluhar GE, McNiel EA, Ohlfest JR, Freese AB, Moore PF, Lerner J, Lowenstein PR, Castro MG (2007) Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J Neuro-Oncol 85:133–148. https://doi.org/10.1007/s11060-007-9400-9 CrossRef

Cao Y (2013) Angiogenesis and vascular functions in modulation of obesity, adipose metabolism, and insulin sensitivity. Cell Metab 18:478–489. https://doi.org/10.1016/j.cmet.2013.08.008 CrossRefPubMed

Carmeliet P (2003) Angiogenesis in health and disease. Nat Med 9:653–660. https://doi.org/10.1038/nm0603-653 CrossRefPubMed

Chen J, McKay RMM, Parada LFF (2012) Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell 149:36–47. https://doi.org/10.1016/j.cell.2012.03.009 CrossRefPubMedPubMedCentral

Coelho P, Almeida J, Prudêncio C, Fernandes R, Soares R (2015) Effect of adipocyte Secretome in melanoma progression and Vasculogenic mimicry. J Cell Biochem 117:1697–1706. https://doi.org/10.1002/jcb.25463 CrossRef

Corvera S, Gealekman O (2014) Adipose tissue angiogenesis: impact on obesity and type-2 diabetes. Biochim Biophys Acta 1842:463–472. https://doi.org/10.1016/j.bbadis.2013.06.003 CrossRefPubMed

Costa C, Soares R, Schmitt F (2004) Angiogenesis: now and then. APMIS 112:402–412. https://doi.org/10.1111/j.1600-0463.2004.apm11207-0802.x CrossRefPubMed

Costa C, Incio J, Soares R (2007) Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 10:149–166. https://doi.org/10.1007/s10456-007-9074-0 CrossRefPubMed

Delehedde M, Devenyns L, Maurage C-A, Vivès RR (2013) Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol 2013:705027. https://doi.org/10.1155/2013/705027 CrossRefPubMedPubMedCentral

Disney-Hogg L, Sud A, Law PJ, Cornish AJ, Kinnersley B, Ostrom QT, Labreche K, Eckel-Passow JE, Armstrong GN, Claus EB, Il’yasova D, Schildkraut J, Barnholtz-Sloan JS, Olson SH, Bernstein JL, Lai RK, Swerdlow AJ, Simon M, Hoffmann P, Nöthen MM, Jöckel KH, Chanock S, Rajaraman P, Johansen C, Jenkins RB, Melin BS, Wrensch MR, Sanson M, Bondy ML, Houlston RS (2018) Influence of obesity-related risk factors in the aetiology of glioma. Br J Cancer 118:1020–1027. https://doi.org/10.1038/s41416-018-0009-x CrossRefPubMedPubMedCentral

Donohoe CL, Lysaght J, O ‘sullivan J, Reynolds J V (2016) Emerging concepts linking obesity with the hallmarks of cancer. https://doi.org/10.1016/j.tem.2016.08.004

Fabregat A, Jupe S, Matthews L, Sidiropoulos K, Gillespie M, Garapati P, Haw R, Jassal B, Korninger F, May B, Milacic M, Roca CD, Rothfels K, Sevilla C, Shamovsky V, Shorser S, Varusai T, Viteri G, Weiser J, Wu G, Stein L, Hermjakob H, D’Eustachio P (2018) The Reactome pathway knowledgebase. Nucleic Acids Res 46:D649–D655. https://doi.org/10.1093/nar/gkx1132 CrossRefPubMed

Gundry RL, White MY, Murray CI et al (2009) Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflow. Curr Protoc Mol Biol Chapter 10:10.25.1–10.25.23. https://doi.org/10.1002/0471142727.mb1025s88 CrossRef

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674. https://doi.org/10.1016/j.cell.2011.02.013 CrossRefPubMed

Hossain A, Gumin J, Gao F, Figueroa J, Shinojima N, Takezaki T, Priebe W, Villarreal D, Kang SG, Joyce C, Sulman E, Wang Q, Marini FC, Andreeff M, Colman H, Lang FF (2015) Mesenchymal stem cells isolated from human gliomas increase proliferation and maintain stemness of glioma stem cells through the IL-6/gp130/STAT3 pathway. Stem Cells 33:2400–2415. https://doi.org/10.1002/stem.2053 CrossRefPubMedPubMedCentral

Huse JT, Holland E, DeAngelis LM (2013) Glioblastoma: molecular analysis and clinical implications. Annu Rev Med 64:59–70. https://doi.org/10.1146/annurev-med-100711-143028 CrossRefPubMed

Khandekar MJ, Cohen P, Spiegelman BM (2011) Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 11:886–895. https://doi.org/10.1038/nrc3174 CrossRefPubMed

Kiliaan AJ, Arnoldussen IA, Gustafson DR (2014) Adipokines: a link between obesity and dementia? IArnoldussen@anatumcnnl. Lancet Neurol 13:913–923. https://doi.org/10.1016/S1474-4422(14)70085-7 CrossRefPubMedPubMedCentral

Lawrence JE, Cook NJ, Rovin RA, Winn RJ (2012) Leptin Promotes Glioblastoma. Neurol Res Int 2012:1–6. https://doi.org/10.1155/2012/870807 CrossRef

Lemoine AY, Ledoux S, Larger E (2013) Adipose tissue angiogenesis in obesity. Thromb Haemost 110:661–669. https://doi.org/10.1160/TH13-01-0073 CrossRefPubMed

Lijnen HR (2008) Angiogenesis and obesity. Cardiovasc Res 78:286–293. https://doi.org/10.1093/cvr/cvm007 CrossRefPubMed

Lokman NA, Ween MP, Oehler MK, Ricciardelli C (2011) The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron 4:199–208. https://doi.org/10.1007/s12307-011-0064-9 CrossRefPubMedPubMedCentral

Luisa A, Stefano D, Enciso-mora V, et al (2012) Association between glioma susceptibility molecular etiologies. 1–6

Matano F, Yoshida D, Ishii Y, Tahara S, Teramoto A, Morita A (2014) Endocan, a new invasion and angiogenesis marker of pituitary adenomas. J Neuro-Oncol 117:485–491. https://doi.org/10.1007/s11060-014-1377-6 CrossRef

Maurage C-A, Adam E, Minéo J-F, Sarrazin S, Debunne M, Siminski RM, Baroncini M, Lassalle P, Blond S, Delehedde M (2009) Endocan expression and localization in human glioblastomas. J Neuropathol Exp Neurol 68:633–641. https://doi.org/10.1097/NEN.0b013e3181a52a7f CrossRefPubMed

Mendonça F, Soares R (2015) Obesity and cancer phenotype: is angiogenesis a missed link? Life Sci 139:16–23. https://doi.org/10.1016/j.lfs.2015.08.009 CrossRefPubMed

Moore SC, Rajaraman P, Dubrow R, Darefsky AS, Koebnick C, Hollenbeck A, Schatzkin A, Leitzmann MF (2009) Height, body mass index, and physical activity in relation to glioma risk. Cancer Res 69:8349–8355. https://doi.org/10.1158/0008-5472.CAN-09-1669 CrossRefPubMedPubMedCentral

Niclou SP, Fack F, Rajcevic U (2010) Glioma proteomics: status and perspectives. J Proteome 73:1823–1838. https://doi.org/10.1016/j.jprot.2010.03.007 CrossRef

Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS (2014) The epidemiology of glioma in adults: a “state of the science” review. Neuro-Oncology 16:896–913. https://doi.org/10.1093/neuonc/nou087 CrossRefPubMedPubMedCentral

Parkin DM, Bray F, Ferlay J, Pisani P (2002) Global cancer statistics. CA Cancer J Clin 55:74–108CrossRef

Patrick W, Kesari S (2008) Malignant Gliomas in Adults. N Engl J Med 359:492–507. https://doi.org/10.1056/NEJMc086380 CrossRef

Pirraco A, Coelho P, Rocha A, Costa R, Vasques L, Soares R (2010) Imatinib targets PDGF signaling in melanoma and host smooth muscle neighboring cells. J Cell Biochem 111:433–441. https://doi.org/10.1002/jcb.22725 CrossRefPubMed

Pi-Sunyer FX (2002) The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 10(Suppl 2):97S–104S. https://doi.org/10.1038/oby.2002.202 CrossRefPubMed

Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Bustos M, Martínez JA, Moreno-Aliaga MJ (2011) Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach. Biochim Biophys Acta 1807:664–678. https://doi.org/10.1016/j.bbabio.2010.11.004 CrossRefPubMed

Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301–316. https://doi.org/10.1146/annurev.med.080708.082713 CrossRefPubMed

Rosenfeld J, Capdevielle J, Guillemot JC, Ferrara P (1992) In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal Biochem 203:173–179. https://doi.org/10.1016/0003-2697(92)90061-B CrossRefPubMed

Shevchenko A, Tomas H, Havlis J et al (2006) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1:2856–2860. https://doi.org/10.1038/nprot.2006.468 CrossRefPubMed

Siegel EM, Nabors LB, Thompson RC, Olson JJ, Browning JE, Madden MH, Han G, Egan KM (2013) Prediagnostic body weight and survival in high grade glioma. J Neuro-Oncol 114:79–84. https://doi.org/10.1007/s11060-013-1150-2 CrossRef

Sielska M, Przanowski P, Wylot B, Gabrusiewicz K, Maleszewska M, Kijewska M, Zawadzka M, Kucharska J, Vinnakota K, Kettenmann H, Kotulska K, Grajkowska W, Kaminska B (2013) Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response. J Pathol 230:310–321. https://doi.org/10.1002/path.4192 CrossRefPubMed

Szatmari T, Lumniczky K, Desaknai S, Trajcevski S, Hidvegi EJ, Hamada H, Safrany G (2006) Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci 97:546–553. https://doi.org/10.1111/j.1349-7006.2006.00208.x CrossRefPubMed

van Kruijsdijk RCM, van der Wall E, Visseren FLJ (2009) Obesity and Cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomark Prev 18:2569–2578. https://doi.org/10.1158/1055-9965.EPI-09-0372 CrossRef

Verpelli C, Bertani G, Cea V, Patti M, Bikfalvi A, Bello L, Sala C (2010) Anti-angiogenic therapy induces integrin-linked kinase 1 up-regulation in a mouse model of glioblastoma. PLoS One 5:1–12. https://doi.org/10.1371/journal.pone.0013710 CrossRef

Wiedmann MKH, Brunborg C, Di Ieva A et al (2017) Overweight, obesity and height as risk factors for meningioma, glioma, pituitary adenoma and nerve sheath tumor: a large population-based prospective cohort study. Acta Oncol (Madr) 56:1302–1309. https://doi.org/10.1080/0284186X.2017.1330554 CrossRef

Wolin KY, Carson K, Colditz G a (2010) Obesity and Cancer. Oncologist 15:556–565. https://doi.org/10.1634/theoncologist.2009-0285 CrossRefPubMedPubMedCentral

Xu M, Yao Y, Hua W, Wu Z, Zhong P, Mao Y, Zhou L, Luo F, Chu Y (2014) Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysate-pulsed dendritic cells. J Neuro-Oncol 116:497–504. https://doi.org/10.1007/s11060-013-1334-9 CrossRef

Yi L, Zhou C, Wang B et al (2013) Implantation of GL261 neurospheres into C57/BL6 mice: a more reliable syngeneic graft model for research on glioma-initiating cells. Int J Oncol 43:477–484. https://doi.org/10.3892/ijo.2013.1962 CrossRefPubMed

Yin J, Gao Z, He Q, Zhou D, Guo ZK, Ye J (2008) Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. AJP Endocrinol Metab 296:E333–E342. https://doi.org/10.1152/ajpendo.90760.2008 CrossRef

Young N, Van Brocklyn JR (2007) Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness. Exp Cell Res 313:1615–1627. https://doi.org/10.1016/j.yexcr.2007.02.009 CrossRefPubMedPubMedCentral

Zhai H, Acharya S, Gravanis I, Mehmood S, Seidman RJ, Shroyer KR, Hajjar KA, Tsirka SE (2011) Annexin A2 promotes glioma cell invasion and tumor progression. J Neurosci 31:14346–14360. https://doi.org/10.1523/JNEUROSCI.3299-11.2011 CrossRefPubMedPubMedCentral

Zhang X, Liu S, Guo C, Zong J, Sun MZ (2012) The association of annexin A2 and cancers. Clin Transl Oncol 14:634–640. https://doi.org/10.1007/s12094-012-0855-6 CrossRefPubMed

Title: Adipocyte proteome and secretome influence inflammatory and hormone pathways in glioma
Authors: J. Almeida
J. Costa
P. Coelho
V. Cea
M. Galesio
J. P. Noronha
M. S. Diniz
C. Prudêncio
R. Soares
C. Sala
Rúben Fernandes
Publication date: 01-02-2019
Publisher: Springer US
Published in: Metabolic Brain Disease / Issue 1/2019
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-018-0327-y

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Adipocyte proteome and secretome influence inflammatory and hormone pathways in glioma

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2019

A novel intronic homozygous mutation in the AMT gene of a patient with nonketotic hyperglycinemia and hyperammonemia

Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing

L-3-n-butylphthalide attenuates cognitive deficits in db/db diabetic mice

Neuroprotective effects of exercise in rodent models of memory deficit and Alzheimer's

Gallic acid activates hippocampal BDNF-Akt-mTOR signaling in chronic mild stress

Neurochemical alterations following the exposure to di-n-butyl phthalate in rats